Long-term SARS Coronavirus Excretion from Patient Cohort, China
Wei Liu*, Fang Tang*, Arnaud Fontanet†, Lin Zhan*, Qiu-Min Zhao*, Pan-He Zhang*, Xiao-Ming Wu*, Shu-Qing Zuo*, Laurence Baril†, Astrid Vabret‡, Zhong-Tao Xin§, Yi-Ming Shao¶, Hong Yang*, and Wu-Chun Cao*
Author affiliations: *Beijing Institute of Microbiology and Epidemiology, Beijing, People’s Republic of China; †Institut Pasteur, Paris, France; ‡Caen University, Paris, France; §Beijing Institute of Basic Medical Sciences, People’s Republic of China; ¶Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of China
Figure. Time to reverse transcription–polymerase chain reaction negativation for sputum and stool specimens among patients with severe acute respiratory syndrome (SARS) (n = 56) at one designated SARS hospital, Beijing, 2003.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.